Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579059 · ClinicalTrials.gov registry record · NA
Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia
A NA study, sponsored by Biomet Orthopedics.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00579059: Clinical Trial NA study, sponsored by Biomet Orthopedics.
NCT00579059 is a NA study that was terminated before completion, run by Biomet Orthopedics. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579059, a NA study, was terminated before completion, sponsored by Biomet Orthopedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim® Pop-Top® Tibia and Maxim® Modular Tibia.
Primary Outcome
The function score is detailed below as a Range; 100 being the highest score, and 0 being the lowest score. 90-100 is considered "Excellent," 60-89 is considered "Good," 30-59 is considered "fair," and 0-29 is considered "poor."
Interventions
- DEVICE Maxim® Knee System with Removable Molded Polyethylene Tibia
- DEVICE Regular Maxim® Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2004-05 |
| Est. Completion | 2007-11 |
| Phase | NA |
Why NCT00579059 stopped before completion
NCT00579059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Maxim® Knee System with Removable Molded Polyethylene Tibia is the first listed.
NCT00579059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579059 about?
NCT00579059 is a clinical study titled "Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia". The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim® Pop-Top® Tibia and Maxim® Modular Tibia.
What is the current status of trial NCT00579059?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2004-05. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00579059?
The interventions under investigation include: Maxim® Knee System with Removable Molded Polyethylene Tibia (DEVICE), Regular Maxim® Knee System (DEVICE).
Who is sponsoring clinical trial NCT00579059?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00579059's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia